Tech stocks live: Stocks fall on AI trade concerns
Nvidia (NVDA) is moving further into the biomedical space with a new software tool that equips AI agents to perform scientific work.
Called the BioNeMo Agent Toolkit, the software is agent-agnostic, meaning it can work with various AI agents, such as OpenAI’s Codex (OPAI.PVT).
According to Nvidia vice president of healthcare Kimberly Powell, the toolkit equips AI agents with the knowledge necessary to perform specific medical research more efficiently.
“In the world of agents, the longer the agent is waiting … the more tokens you will be burning. And so we need to have accelerated tools for the agents to work with,” Powell explained.
Think of the BioNeMo toolkit as a crash course in specific scientific and medical understanding for an AI agent.
Asking a general agent like OpenAI’s Codex or Anthropic’s (ANTH.PVT) Claude for highly specialized medical or scientific questions, Powell explained, would likely take some time, if the agents could answer at all.